Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial
Condition(s):Neuromuscular BlocksLast Updated:March 19, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Neuromuscular BlocksLast Updated:March 19, 2024Not yet recruiting
Condition(s):SnoringLast Updated:July 2, 2019Terminated
Condition(s):Muscle Relaxant; General AnesthesiaLast Updated:August 18, 2017Completed
Condition(s):SugammadexLast Updated:March 10, 2022Unknown status
Condition(s):Supraglottic Airway Device InsertionLast Updated:September 10, 2020Unknown status
Condition(s):Neuromuscular Block, ResidualLast Updated:April 24, 2023Recruiting
Condition(s):Sugammadex; NeostigmineLast Updated:October 13, 2023Active, not recruiting
Condition(s):Cardiac CatheterizationLast Updated:June 16, 2021Completed
Condition(s):Neuromuscular BlockadeLast Updated:May 2, 2017Completed
Condition(s):Neuromuscular Blockade; Sugammadex; Neostigmine; Complication of Anesthesia; Postoperative Residual Curarization; RocuroniumLast Updated:October 4, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.